Lantern Pharma Inc. Research And Development Expense

Quick Answer

Lantern Pharma Inc. reported Research And Development Expense of $11.51 million for the year ending 2025.

  • Lantern Pharma Inc. showed a decrease of -28.6% in Research And Development Expense from 2024 to 2025.
  • This data is from Lantern Pharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Lantern Pharma Inc.'s Research And Development Expense has grown by 413.3%.
  • Historical annual values: Fiscal year 2025: $11.51 million | Fiscal year 2024: $16.13 million | Fiscal year 2023: $11.89 million | Fiscal year 2022: $8.60 million | Fiscal year 2021: $7.57 million | Fiscal year 2020: $2.24 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: